Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...

Gastritis III: Clinical Manifestations and Management

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

Gastritis-I: Introduction and Types

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hyperbaric oxygen therapy for chronic antibiotic-refractory ischemic pouchitis.

Gastroenterology report·2015

Same author

The interaction of Gα13 with integrin β1 mediates cell migration by dynamic regulation of RhoA.

Molecular biology of the cell·2015

Same author

Overcoming difficulty in diagnosis and differential diagnosis of Crohn's disease: the potential role of serological and genetic tests.

Expert review of molecular diagnostics·2015

Same author

The presence of primary sclerosing cholangitis in patients with ileal pouch anal- anastomosis is associated with an additional risk for vitamin D deficiency.

Gastroenterology report·2015

Same author

Perioperative Blood Transfusion and Postoperative Outcome in Patients with Crohn's Disease Undergoing Primary Ileocolonic Resection in the "Biological Era".

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2015

Same author

Postoperative Fluid Overload is a Useful Predictor of the Short-Term Outcome of Renal Replacement Therapy for Acute Kidney Injury After Cardiac Surgery.

Medicine·2015

Search research articles

Related Experiment Video

Updated: May 12, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Pouchitis: what every gastroenterologist needs to know.

¹Department of Gastroenterology/Hepatology, Digestive Disease Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association

|April 23, 2013

Summary

This summary is machine-generated.

Pouchitis, a complication after ulcerative colitis surgery, presents a spectrum of diseases. Identifying secondary factors is key to managing refractory pouchitis when antibiotics fail.

Keywords:

CARD15 CARP CD CDI CMV Clostridium difficile infection Crohn's disease FAP IBD IL IPAA IPS Ileal Pouch NOD2 NSAID PSC Pouchitis Restorative Proctocolectomy TNF UC Ulcerative Colitis caspase recruitment domain family, member 15 chronic antibiotic-refractory pouchitis cytomegalovirus familial adenomatous polyposis ileal pouch-anal anastomosis inflammatory bowel disease interleukin irritable pouch syndrome nonsteroidal anti-inflammatory drug nucleotide-binding oligomerization domain containing 2 primary sclerosing cholangitis tumor necrosis factor ulcerative colitis

Related Experiment Videos

Last Updated: May 12, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Area of Science:

Gastroenterology
Colorectal Surgery
Inflammatory Bowel Disease

Background:

Pouchitis is the most frequent complication following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
It represents a spectrum of conditions with diverse causes, presentations, and outcomes.
While acute pouchitis often responds to antibiotics, some patients develop antibiotic dependence or refractory disease.

Purpose of the Study:

To elucidate the multifactorial nature of refractory pouchitis.
To highlight the importance of identifying secondary contributors to refractory pouchitis.
To guide therapeutic strategies for complex pouchitis cases.

Main Methods:

Review of existing literature on pouchitis etiology and management.
Analysis of factors contributing to refractory pouchitis.
Synthesis of information on diagnostic and therapeutic approaches.

Main Results:

Refractory pouchitis is influenced by various factors including NSAID use, C. difficile infection, pouch ischemia, and other immune disorders.
These secondary factors play a significant role in the disease's clinical course.
Effective management requires identifying and addressing these specific contributing elements.

Conclusions:

Understanding the spectrum of pouchitis and its secondary causes is crucial for effective treatment.
Targeting specific contributing factors beyond initial antibiotic therapy can improve outcomes in refractory cases.
Further research into the precise mechanisms and tailored therapies for refractory pouchitis is warranted.